Effects of Aliskiren/Amlodipine Versus Amlodipine Monotherapy on Ankle-foot Volume in Hypertensive Patients | NCT01048047 | Trialant
Unknown statusInterventionalPhase 4Updated Jan 13, 2010
Effects of Aliskiren/Amlodipine Versus Amlodipine Monotherapy on Ankle-foot Volume in Hypertensive Patients
ClinicalTrials.gov ID
NCT01048047
Lead Sponsor
University of PaviaOTHER
Overall Status
Unknown status
Study Type
Interventional
Phase
Phase 4
Enrollment
88Estimated
Last Update Posted
Jan 13, 2010Estimated
Start Date
Nov 2009
Primary Completion Date
Dec 2009Estimated
Completion Date
Mar 2010Estimated
Brief Summary
Comparison between the effect of aliskiren/amlodipine combination with amlodipine monotherapy on ankle-foot volume in hypertensive patients. It will be enrolled male or female outpatients, aged 18-65 years.